Home
Subscriptions
Chat
Activity
Explore
Profile
Create
Make money doing the work you believe in
Start your Substack
Learn more
For you
The M&A Hunter
4d
@maandhunter
Alpha Tau REGAIN Interim Hits. Glioblastoma Joins the Platform Story.
This is the kind of morning that resets a thesis. Alpha Tau Medical (DRTS) dropped its REGAIN interim before the open. Three patients treated for recurrent glioblastoma at The Ohio State University C…
The M&A Hunter
May 11
at
12:50 PM
Relevant people
Log in or sign up
Join the most interesting and insightful discussions.
Start your Substack
Sign in
Get app
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts